New York State Common Retirement Fund Vanda Pharmaceuticals Inc. Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 11,376 shares of VNDA stock, worth $50,054. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,376
Previous 11,376 -0.0%
Holding current value
$50,054
Previous $64,000 17.19%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
BUY
$3.91 - $6.5 $191 - $318
49 Added 0.43%
11,376 $64,000
Q1 2024

May 07, 2024
SELL
$3.47 - $4.61 $225 - $299
-65 Reduced 0.57%
11,327 $47,000
Q4 2023

Feb 01, 2024
SELL
$3.38 - $4.58 $21,675 - $29,371
-6,413 Reduced 36.02%
11,392 $48,000
Q3 2023

Nov 07, 2023
BUY
$4.28 - $6.57 $27,691 - $42,507
6,470 Added 57.08%
17,805 $77,000
Q2 2023

Aug 07, 2023
SELL
$5.9 - $6.95 $362,012 - $426,438
-61,358 Reduced 84.41%
11,335 $75,000
Q1 2023

May 02, 2023
BUY
$6.18 - $7.99 $205,899 - $266,202
33,317 Added 84.61%
72,693 $494,000
Q4 2022

Jan 30, 2023
SELL
$6.87 - $10.96 $158 - $252
-23 Reduced 0.06%
39,376 $291,000
Q3 2022

Nov 08, 2022
SELL
$9.44 - $11.76 $483,601 - $602,453
-51,229 Reduced 56.53%
39,399 $389,000
Q2 2022

Aug 04, 2022
BUY
$9.31 - $11.84 $476,066 - $605,438
51,135 Added 129.48%
90,628 $988,000
Q1 2022

May 05, 2022
BUY
$10.84 - $16.55 $357 - $546
33 Added 0.08%
39,493 $447,000
Q4 2021

Feb 02, 2022
SELL
$15.69 - $21.14 $514,726 - $693,518
-32,806 Reduced 45.4%
39,460 $619,000
Q3 2021

Nov 02, 2021
BUY
$15.35 - $21.27 $393,159 - $544,788
25,613 Added 54.9%
72,266 $1.24 Million
Q2 2021

Aug 02, 2021
BUY
$15.71 - $21.51 $7,116 - $9,744
453 Added 0.98%
46,653 $1 Million
Q1 2021

May 11, 2021
BUY
$13.42 - $20.28 $14,762 - $22,308
1,100 Added 2.44%
46,200 $694,000
Q4 2019

Feb 05, 2020
SELL
$12.38 - $17.47 $84,184 - $118,795
-6,800 Reduced 13.1%
45,100 $740,000
Q4 2018

Feb 08, 2019
SELL
$18.97 - $31.47 $98,644 - $163,644
-5,200 Reduced 9.11%
51,900 $1.36 Million
Q3 2018

Nov 07, 2018
SELL
$18.25 - $23.0 $114,427 - $144,210
-6,270 Reduced 9.89%
57,100 $1.31 Million
Q2 2018

Aug 10, 2018
BUY
$13.95 - $19.15 $139,500 - $191,500
10,000 Added 18.74%
63,370 $1.21 Million
Q2 2017

Aug 11, 2017
BUY
N/A
53,370
53,370 $870,000

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $249M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email